Page last updated: 2024-08-21

testosterone enanthate and Cancer of Prostate

testosterone enanthate has been researched along with Cancer of Prostate in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Izumi, K; Kadono, Y; Mizokami, A; Nanjo, S; Narimoto, K; Nohara, T; Ohtsubo, K; Shigehara, K; Yamada, T; Yano, S1
Bostwick, DG; Dorey, FJ; Epstein, JI; Hess, DL; Macairan, ML; Makarov, DV; Marks, LS; Mazer, NA; Mostaghel, E; Nelson, PS; Partin, AW; Veltri, RW1
Kawaoi, A; Komatsu, H; Maezawa, H; Ueno, A1

Trials

2 trial(s) available for testosterone enanthate and Cancer of Prostate

ArticleYear
Androgen replacement therapy for cancer-related symptoms in male advanced cancer patients: study protocol for a randomised prospective trial (ARTFORM study).
    The journal of medical investigation : JMI, 2017, Volume: 64, Issue:3.4

    Topics: Clinical Protocols; Hormone Replacement Therapy; Humans; Injections, Intramuscular; Male; Prospective Studies; Prostatic Neoplasms; Quality of Life; Testosterone

2017
Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.
    JAMA, 2006, Nov-15, Volume: 296, Issue:19

    Topics: Adult; Age of Onset; Aged; Biopsy, Needle; Dihydrotestosterone; Double-Blind Method; Epithelial Cells; Gene Expression Profiling; Hormone Replacement Therapy; Humans; Hypogonadism; Male; Middle Aged; Oligonucleotide Array Sequence Analysis; Prostate; Prostatic Neoplasms; RNA; Testosterone

2006

Other Studies

1 other study(ies) available for testosterone enanthate and Cancer of Prostate

ArticleYear
Potentiating effect of buserelin acetate, an LHRH agonist, on the proliferation of ventral prostatic epithelial cells in testosterone-treated castrated rats.
    International journal of urology : official journal of the Japanese Urological Association, 1997, Volume: 4, Issue:4

    Topics: Animals; Antineoplastic Agents, Hormonal; Buserelin; Cell Division; Cell Nucleus; Contraceptive Agents, Male; Dose-Response Relationship, Drug; Drug Synergism; Epithelial Cells; Epithelium; Gonadotropin-Releasing Hormone; Luteinizing Hormone; Male; Orchiectomy; Proliferating Cell Nuclear Antigen; Prostatic Neoplasms; Rats; Rats, Wistar; Testosterone

1997